Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Medical Devices & Consumables > Global AI Imaging & Diagnostics Market Outlook, In‑Depth Analysis & Forecast to 2032

Global AI Imaging & Diagnostics Market Outlook, In‑Depth Analysis & Forecast to 2032

Industry: Medical Devices & Consumables

Published: 2026-03-10

Pages: 188 Pages

Report ld: 6143377

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

The global AI Imaging & Diagnostics market is projected to grow from US$ 7259 million in 2025 to US$ 27453 million by 2032, at a CAGR of 20.9% (2026-2032), driven by critical product segments and diverse end‑use applications.

AI Imaging & Diagnostics refers to the integrated market of artificial intelligence technologies applied to medical imaging analysis and broader clinical diagnostic decision-making. It includes AI systems that analyze imaging data such as X-ray, CT, MRI, ultrasound, mammography, and digital pathology, as well as solutions that combine imaging with non-imaging clinical inputs (e.g., physiological signals, structured EHR data) to support diagnosis. These products are typically commercialized as regulated Software as a Medical Device (SaMD) or embedded into imaging equipment and clinical IT systems such as PACS, RIS, and EHRs. AI Imaging & Diagnostics enhances diagnostic accuracy, standardization, and efficiency while keeping physicians in the loop, addressing rising imaging volumes, workforce shortages, and the need for earlier and more consistent disease detection.

AI Imaging & Diagnostics Market Size(US$)

M= millions and B=billions

The market can be classified by data type (imaging-based, signal-based, multi-modal), by clinical function (detection, segmentation, classification, severity scoring, diagnostic recommendation), by medical specialty (radiology, cardiology, oncology, neurology, ophthalmology, primary care), by deployment model (on-premise, cloud SaaS, device-embedded, edge-based), and by regulatory/commercial type (standalone SaMD, bundled software, clinical decision support, screening-focused solutions). These dimensions reflect both technical complexity and commercial pathways.

Key costs arise from data acquisition and labeling, algorithm development, clinical trials, regulatory compliance, and continuous model updates. With software-centric economics, gross margins generally range from 65% to 80%. Transactions are dominated by subscription SaaS, per-study pricing, and multi-year enterprise licenses, often bundled with imaging systems or workflow platforms. Market trends include rapid regulatory approvals, consolidation through M&A, deeper OEM integration, expansion beyond radiology into multi-disciplinary diagnostics, and accelerating adoption driven by value-based care and clinician shortages.

Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global AI Imaging & Diagnostics market across value chain. It analyzes historical revenue data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.

Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players (revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middle stream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Report Metric
Details
Report Title
Global AI Imaging & Diagnostics Market Outlook, In‑Depth Analysis & Forecast to 2032
Forecasted Market Size in 2032
US$ 27453 million
CAGR(2026-2032)
20.9%
Market Size Available for Years
2026-2032
Global AI Imaging & Diagnostics Companies Covered
Butterfly Network
Merative
Tempus
RetinAi
Nanox
Lunit
DiA Imaging
Subtle Medical
BrainMiner
GE
Siemens
Aidoc
Imagen Technologies, Inc.
VUNO, Inc.
Digital Diagnostics
NeuraSignal
Riverain Technologies, LLC
Philips
Microsoft
Viz.ai
RapidAI
Canon Medical
Enlitic
BioMind
ANNALISE-AI PTY LTD
icometrix
KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO）
Global AI Imaging & Diagnostics Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global AI Imaging & Diagnostics Market, Segment by Type
X-ray / CXR
CT
MRI
Ultrasound
Mammography / DBT
Others
Global AI Imaging & Diagnostics Market, Segment by Application
Radiology & Imaging
Cardiology
Neurology
Ophthalmology
Oncology
Primary Care
Others
Product Category
Medical Imaging–based
Physiological Signals–based
Ophthalmic Imaging–based
Others
Market Segment
On-prem
Cloud SaaS
Edge / Embedded
Hybrid
Others
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Defines the AI Imaging & Diagnostics study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape: ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down market size by Application and country, profiles key players and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional market by Application and players, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies market size by Application, and region/country, profiles top players, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures market size by Application, and country, profiles top players, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates market size by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth: details product specs, revenue, margins; top-tier players 2025 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments
Chapter 12: Value chain and ecosystem: analyses upstream, midstream, plus downstream channels
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

Table of Contents

1 Study Coverage
    1.1 Introduction to AI Imaging & Diagnostics: Definition, Properties, and Key Attributes
    1.2 Market Segmentation by Type
        1.2.1 Global AI Imaging & Diagnostics Market Size by Type, 2021 vs 2025 vs 2032
        1.2.2 X-ray / CXR
        1.2.3 CT
        1.2.4 MRI
        1.2.5 Ultrasound
        1.2.6 Mammography / DBT
        1.2.7 Others
    1.3 Market Segmentation by Diagnostic Data Type
        1.3.1 Global AI Imaging & Diagnostics Market Size by Diagnostic Data Type, 2021 vs 2025 vs 2032
        1.3.2 Medical Imaging–based
        1.3.3 Physiological Signals–based
        1.3.4 Ophthalmic Imaging–based
        1.3.5 Others
    1.4 Market Segmentation by Deployment & Delivery
        1.4.1 Global AI Imaging & Diagnostics Market Size by Deployment & Delivery, 2021 vs 2025 vs 2032
        1.4.2 On-prem
        1.4.3 Cloud SaaS
        1.4.4 Edge / Embedded
        1.4.5 Hybrid
        1.4.6 Others
    1.5 Market Segmentation by Application
        1.5.1 Global AI Imaging & Diagnostics Market Size by Application, 2021 vs 2025 vs 2032
        1.5.2 Radiology & Imaging
        1.5.3 Cardiology
        1.5.4 Neurology
        1.5.5 Ophthalmology
        1.5.6 Oncology
        1.5.7 Primary Care
        1.5.8 Others
    1.6 Assumptions and Limitations
    1.7 Study Objectives
    1.8 Years Considered

2 Executive Summary
    2.1 Global AI Imaging & Diagnostics Revenue Estimates and Forecasts (2021-2032)
    2.2 Global AI Imaging & Diagnostics Revenue by Region
        2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
        2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
        2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
        2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competitive Landscape
    3.1 Global AI Imaging & Diagnostics Players’ Revenue Rankings and Profitability
        3.1.1 Global Revenue (Value) by Players (2021-2026)
        3.1.2 Global Key Players’ Revenue Ranking (2024 vs 2025)
        3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
        3.1.4 Gross Margin by Top Players (2021 vs 2025)
    3.2 Global AI Imaging & Diagnostics Companies Headquarters and Service Footprint
    3.3 Key Player Market Share by Product Type
        3.3.1 X-ray / CXR: Market Share by Key Players
        3.3.2 CT: Market Share by Key Players
        3.3.3 MRI: Market Share by Key Players
        3.3.4 Ultrasound: Market Share by Key Players
        3.3.5 Mammography / DBT: Market Share by Key Players
        3.3.6 Others: Market Share by Key Players
    3.4 Global AI Imaging & Diagnostics Market Concentration and Dynamics
        3.4.1 Global Market Concentration
        3.4.2 Market Entry and Exit Analysis
        3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Product Segmentation
    4.1 Global AI Imaging & Diagnostics Market by Type
        4.1.1 Global Revenue by Type (2021-2032)
        4.1.2 Global Revenue-Based Market Share by Type (2021-2032)
    4.2 Global AI Imaging & Diagnostics Market by Diagnostic Data Type
        4.2.1 Global Revenue by Diagnostic Data Type (2021-2032)
        4.2.2 Global Revenue-Based Market Share by Diagnostic Data Type (2021-2032)
    4.3 Global AI Imaging & Diagnostics Market by Deployment & Delivery
        4.3.1 Global Revenue by Deployment & Delivery (2021-2032)
        4.3.2 Global Revenue-Based Market Share by Deployment & Delivery (2021-2032)
    4.4 Key Product Attributes and Differentiation
    4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
        4.5.1 High-Growth Niches and Adoption Drivers
        4.5.2 Profitability Hotspots and Cost Drivers
        4.5.3 Substitution Threats

5 Downstream Applications and Customers
    5.1 Global AI Imaging & Diagnostics Revenue by Application
        5.1.1 Global Historical and Forecasted Revenue by Application (2021-2032)
        5.1.2 Revenue-Based Market Share by Application (2021-2032)
        5.1.3 High-Growth Application Identification
        5.1.4 Emerging Application Case Studies
    5.2 Downstream Customer Analysis
        5.2.1 Top Customers by Region
        5.2.2 Top Customers by Application

6 North America
    6.1 North America Market Size (2021-2032)
    6.2 North America Key Players’ Revenue in 2025
    6.3 North America AI Imaging & Diagnostics Market Size by Application (2021-2032)
    6.4 North America Growth Accelerators and Market Barriers
    6.5 North America AI Imaging & Diagnostics Market Size by Country
        6.5.1 North America Revenue Trends by Country
        6.5.2 US
        6.5.3 Canada
        6.5.4 Mexico

7 Europe
    7.1 Europe Market Size (2021-2032)
    7.2 Europe Key Players’ Revenue in 2025
    7.3 Europe AI Imaging & Diagnostics Market Size by Application (2021-2032)
    7.4 Europe Growth Accelerators and Market Barriers
    7.5 Europe AI Imaging & Diagnostics Market Size by Country
        7.5.1 Europe Revenue Trends by Country
        7.5.2 Germany
        7.5.3 France
        7.5.4 U.K.
        7.5.5 Italy
        7.5.6 Russia

8 Asia-Pacific
    8.1 Asia-Pacific Market Size (2021-2032)
    8.2 Asia-Pacific Key Players’ Revenue in 2025
    8.3 Asia-Pacific AI Imaging & Diagnostics Market Size by Application (2021-2032)
    8.4 Asia-Pacific Growth Accelerators and Market Barriers
    8.5 Asia-Pacific AI Imaging & Diagnostics Market Size by Region
        8.5.1 Asia-Pacific Revenue Trends by Region
    8.6 China
    8.7 Japan
    8.8 South Korea
    8.9 Australia
    8.10 India
    8.11 Southeast Asia
        8.11.1 Indonesia
        8.11.2 Vietnam
        8.11.3 Malaysia
        8.11.4 Philippines
        8.11.5 Singapore

9 Central and South America
    9.1 Central and South America Market Size (2021-2032)
    9.2 Central and South America Key Players’ Revenue in 2025
    9.3 Central and South America AI Imaging & Diagnostics Market Size by Application (2021-2032)
    9.4 Central and South America Investment Opportunities and Key Challenges
    9.5 Central and South America AI Imaging & Diagnostics Market Size by Country
        9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
        9.5.2 Brazil
        9.5.3 Argentina

10 Middle East and Africa
    10.1 Middle East and Africa Market Size (2021-2032)
    10.2 Middle East and Africa Key Players’ Revenue in 2025
    10.3 Middle East and Africa AI Imaging & Diagnostics Market Size by Application (2021-2032)
    10.4 Middle East and Africa Investment Opportunities and Key Challenges
    10.5 Middle East and Africa AI Imaging & Diagnostics Market Size by Country
        10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
        10.5.2 GCC Countries
        10.5.3 Israel
        10.5.4 Egypt
        10.5.5 South Africa

11 Corporate Profile
    11.1 Butterfly Network
        11.1.1 Butterfly Network Corporation Information
        11.1.2 Butterfly Network Business Overview
        11.1.3 Butterfly Network AI Imaging & Diagnostics Product Features and Attributes
        11.1.4 Butterfly Network AI Imaging & Diagnostics Revenue and Gross Margin (2021-2026)
        11.1.5 Butterfly Network AI Imaging & Diagnostics Revenue by Product in 2025
        11.1.6 Butterfly Network AI Imaging & Diagnostics Revenue by Application in 2025
        11.1.7 Butterfly Network AI Imaging & Diagnostics Revenue by Geographic Area in 2025
        11.1.8 Butterfly Network AI Imaging & Diagnostics SWOT Analysis
        11.1.9 Butterfly Network Recent Developments
    11.2 Merative
        11.2.1 Merative Corporation Information
        11.2.2 Merative Business Overview
        11.2.3 Merative AI Imaging & Diagnostics Product Features and Attributes
        11.2.4 Merative AI Imaging & Diagnostics Revenue and Gross Margin (2021-2026)
        11.2.5 Merative AI Imaging & Diagnostics Revenue by Product in 2025
        11.2.6 Merative AI Imaging & Diagnostics Revenue by Application in 2025
        11.2.7 Merative AI Imaging & Diagnostics Revenue by Geographic Area in 2025
        11.2.8 Merative AI Imaging & Diagnostics SWOT Analysis
        11.2.9 Merative Recent Developments
    11.3 Tempus
        11.3.1 Tempus Corporation Information
        11.3.2 Tempus Business Overview
        11.3.3 Tempus AI Imaging & Diagnostics Product Features and Attributes
        11.3.4 Tempus AI Imaging & Diagnostics Revenue and Gross Margin (2021-2026)
        11.3.5 Tempus AI Imaging & Diagnostics Revenue by Product in 2025
        11.3.6 Tempus AI Imaging & Diagnostics Revenue by Application in 2025
        11.3.7 Tempus AI Imaging & Diagnostics Revenue by Geographic Area in 2025
        11.3.8 Tempus AI Imaging & Diagnostics SWOT Analysis
        11.3.9 Tempus Recent Developments
    11.4 RetinAi
        11.4.1 RetinAi Corporation Information
        11.4.2 RetinAi Business Overview
        11.4.3 RetinAi AI Imaging & Diagnostics Product Features and Attributes
        11.4.4 RetinAi AI Imaging & Diagnostics Revenue and Gross Margin (2021-2026)
        11.4.5 RetinAi AI Imaging & Diagnostics Revenue by Product in 2025
        11.4.6 RetinAi AI Imaging & Diagnostics Revenue by Application in 2025
        11.4.7 RetinAi AI Imaging & Diagnostics Revenue by Geographic Area in 2025
        11.4.8 RetinAi AI Imaging & Diagnostics SWOT Analysis
        11.4.9 RetinAi Recent Developments
    11.5 Nanox
        11.5.1 Nanox Corporation Information
        11.5.2 Nanox Business Overview
        11.5.3 Nanox AI Imaging & Diagnostics Product Features and Attributes
        11.5.4 Nanox AI Imaging & Diagnostics Revenue and Gross Margin (2021-2026)
        11.5.5 Nanox AI Imaging & Diagnostics Revenue by Product in 2025
        11.5.6 Nanox AI Imaging & Diagnostics Revenue by Application in 2025
        11.5.7 Nanox AI Imaging & Diagnostics Revenue by Geographic Area in 2025
        11.5.8 Nanox AI Imaging & Diagnostics SWOT Analysis
        11.5.9 Nanox Recent Developments
    11.6 Lunit
        11.6.1 Lunit Corporation Information
        11.6.2 Lunit Business Overview
        11.6.3 Lunit AI Imaging & Diagnostics Product Features and Attributes
        11.6.4 Lunit AI Imaging & Diagnostics Revenue and Gross Margin (2021-2026)
        11.6.5 Lunit Recent Developments
    11.7 DiA Imaging
        11.7.1 DiA Imaging Corporation Information
        11.7.2 DiA Imaging Business Overview
        11.7.3 DiA Imaging AI Imaging & Diagnostics Product Features and Attributes
        11.7.4 DiA Imaging AI Imaging & Diagnostics Revenue and Gross Margin (2021-2026)
        11.7.5 DiA Imaging Recent Developments
    11.8 Subtle Medical
        11.8.1 Subtle Medical Corporation Information
        11.8.2 Subtle Medical Business Overview
        11.8.3 Subtle Medical AI Imaging & Diagnostics Product Features and Attributes
        11.8.4 Subtle Medical AI Imaging & Diagnostics Revenue and Gross Margin (2021-2026)
        11.8.5 Subtle Medical Recent Developments
    11.9 BrainMiner
        11.9.1 BrainMiner Corporation Information
        11.9.2 BrainMiner Business Overview
        11.9.3 BrainMiner AI Imaging & Diagnostics Product Features and Attributes
        11.9.4 BrainMiner AI Imaging & Diagnostics Revenue and Gross Margin (2021-2026)
        11.9.5 BrainMiner Recent Developments
    11.10 GE
        11.10.1 GE Corporation Information
        11.10.2 GE Business Overview
        11.10.3 GE AI Imaging & Diagnostics Product Features and Attributes
        11.10.4 GE AI Imaging & Diagnostics Revenue and Gross Margin (2021-2026)
        11.10.5 Company Ten Recent Developments
    11.11 Siemens
        11.11.1 Siemens Corporation Information
        11.11.2 Siemens Business Overview
        11.11.3 Siemens AI Imaging & Diagnostics Product Features and Attributes
        11.11.4 Siemens AI Imaging & Diagnostics Revenue and Gross Margin (2021-2026)
        11.11.5 Siemens Recent Developments
    11.12 Aidoc
        11.12.1 Aidoc Corporation Information
        11.12.2 Aidoc Business Overview
        11.12.3 Aidoc AI Imaging & Diagnostics Product Features and Attributes
        11.12.4 Aidoc AI Imaging & Diagnostics Revenue and Gross Margin (2021-2026)
        11.12.5 Aidoc Recent Developments
    11.13 Imagen Technologies, Inc.
        11.13.1 Imagen Technologies, Inc. Corporation Information
        11.13.2 Imagen Technologies, Inc. Business Overview
        11.13.3 Imagen Technologies, Inc. AI Imaging & Diagnostics Product Features and Attributes
        11.13.4 Imagen Technologies, Inc. AI Imaging & Diagnostics Revenue and Gross Margin (2021-2026)
        11.13.5 Imagen Technologies, Inc. Recent Developments
    11.14 VUNO, Inc.
        11.14.1 VUNO, Inc. Corporation Information
        11.14.2 VUNO, Inc. Business Overview
        11.14.3 VUNO, Inc. AI Imaging & Diagnostics Product Features and Attributes
        11.14.4 VUNO, Inc. AI Imaging & Diagnostics Revenue and Gross Margin (2021-2026)
        11.14.5 VUNO, Inc. Recent Developments
    11.15 Digital Diagnostics
        11.15.1 Digital Diagnostics Corporation Information
        11.15.2 Digital Diagnostics Business Overview
        11.15.3 Digital Diagnostics AI Imaging & Diagnostics Product Features and Attributes
        11.15.4 Digital Diagnostics AI Imaging & Diagnostics Revenue and Gross Margin (2021-2026)
        11.15.5 Digital Diagnostics Recent Developments
    11.16 NeuraSignal
        11.16.1 NeuraSignal Corporation Information
        11.16.2 NeuraSignal Business Overview
        11.16.3 NeuraSignal AI Imaging & Diagnostics Product Features and Attributes
        11.16.4 NeuraSignal AI Imaging & Diagnostics Revenue and Gross Margin (2021-2026)
        11.16.5 NeuraSignal Recent Developments
    11.17 Riverain Technologies, LLC
        11.17.1 Riverain Technologies, LLC Corporation Information
        11.17.2 Riverain Technologies, LLC Business Overview
        11.17.3 Riverain Technologies, LLC AI Imaging & Diagnostics Product Features and Attributes
        11.17.4 Riverain Technologies, LLC AI Imaging & Diagnostics Revenue and Gross Margin (2021-2026)
        11.17.5 Riverain Technologies, LLC Recent Developments
    11.18 Philips
        11.18.1 Philips Corporation Information
        11.18.2 Philips Business Overview
        11.18.3 Philips AI Imaging & Diagnostics Product Features and Attributes
        11.18.4 Philips AI Imaging & Diagnostics Revenue and Gross Margin (2021-2026)
        11.18.5 Philips Recent Developments
    11.19 Microsoft
        11.19.1 Microsoft Corporation Information
        11.19.2 Microsoft Business Overview
        11.19.3 Microsoft AI Imaging & Diagnostics Product Features and Attributes
        11.19.4 Microsoft AI Imaging & Diagnostics Revenue and Gross Margin (2021-2026)
        11.19.5 Microsoft Recent Developments
    11.20 Viz.ai
        11.20.1 Viz.ai Corporation Information
        11.20.2 Viz.ai Business Overview
        11.20.3 Viz.ai AI Imaging & Diagnostics Product Features and Attributes
        11.20.4 Viz.ai AI Imaging & Diagnostics Revenue and Gross Margin (2021-2026)
        11.20.5 Viz.ai Recent Developments
    11.21 RapidAI
        11.21.1 RapidAI Corporation Information
        11.21.2 RapidAI Business Overview
        11.21.3 RapidAI AI Imaging & Diagnostics Product Features and Attributes
        11.21.4 RapidAI AI Imaging & Diagnostics Revenue and Gross Margin (2021-2026)
        11.21.5 RapidAI Recent Developments
    11.22 Canon Medical
        11.22.1 Canon Medical Corporation Information
        11.22.2 Canon Medical Business Overview
        11.22.3 Canon Medical AI Imaging & Diagnostics Product Features and Attributes
        11.22.4 Canon Medical AI Imaging & Diagnostics Revenue and Gross Margin (2021-2026)
        11.22.5 Canon Medical Recent Developments
    11.23 Enlitic
        11.23.1 Enlitic Corporation Information
        11.23.2 Enlitic Business Overview
        11.23.3 Enlitic AI Imaging & Diagnostics Product Features and Attributes
        11.23.4 Enlitic AI Imaging & Diagnostics Revenue and Gross Margin (2021-2026)
        11.23.5 Enlitic Recent Developments
    11.24 BioMind
        11.24.1 BioMind Corporation Information
        11.24.2 BioMind Business Overview
        11.24.3 BioMind AI Imaging & Diagnostics Product Features and Attributes
        11.24.4 BioMind AI Imaging & Diagnostics Revenue and Gross Margin (2021-2026)
        11.24.5 BioMind Recent Developments
    11.25 ANNALISE-AI PTY LTD
        11.25.1 ANNALISE-AI PTY LTD Corporation Information
        11.25.2 ANNALISE-AI PTY LTD Business Overview
        11.25.3 ANNALISE-AI PTY LTD AI Imaging & Diagnostics Product Features and Attributes
        11.25.4 ANNALISE-AI PTY LTD AI Imaging & Diagnostics Revenue and Gross Margin (2021-2026)
        11.25.5 ANNALISE-AI PTY LTD Recent Developments
    11.26 icometrix
        11.26.1 icometrix Corporation Information
        11.26.2 icometrix Business Overview
        11.26.3 icometrix AI Imaging & Diagnostics Product Features and Attributes
        11.26.4 icometrix AI Imaging & Diagnostics Revenue and Gross Margin (2021-2026)
        11.26.5 icometrix Recent Developments
    11.27 KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO）
        11.27.1 KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO） Corporation Information
        11.27.2 KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO） Business Overview
        11.27.3 KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO） AI Imaging & Diagnostics Product Features and Attributes
        11.27.4 KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO） AI Imaging & Diagnostics Revenue and Gross Margin (2021-2026)
        11.27.5 KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO） Recent Developments

12 AI Imaging & Diagnostics Value Chain and Ecosystem Analysis
    12.1 AI Imaging & Diagnostics Value Chain (Ecosystem Structure)
    12.2 Upstream Analysis
        12.2.1 Key Technologies, Platforms and Infrastructure
    12.3 Midstream Analysis
    12.4 Downstream Sales Model and Distribution Networks
        12.4.1 Sales Channels
        12.4.2 Distributors

13 AI Imaging & Diagnostics Market Dynamics
    13.1 Industry Trends and Evolution
    13.2 Market Growth Drivers and Emerging Opportunities
    13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global AI Imaging & Diagnostics Study

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Author Details

Table of Figures

List of Tables
 Table 1. Global AI Imaging & Diagnostics Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
 Table 2. Global AI Imaging & Diagnostics Market Size Growth Rate by Diagnostic Data Type, 2021 vs 2025 vs 2032 (US$ Million)
 Table 3. Global AI Imaging & Diagnostics Market Size Growth Rate by Deployment & Delivery, 2021 vs 2025 vs 2032 (US$ Million)
 Table 4. Global AI Imaging & Diagnostics Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
 Table 5. Global AI Imaging & Diagnostics Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 6. Global AI Imaging & Diagnostics Revenue by Region (US$ Million), 2021-2026
 Table 7. Global AI Imaging & Diagnostics Revenue by Region (US$ Million), 2027-2032
 Table 8. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
 Table 9. Global AI Imaging & Diagnostics Revenue by Players (US$ Million), 2021-2026
 Table 10. Global AI Imaging & Diagnostics Revenue-Based Market Share by Players (2021-2026)
 Table 11. Global Key Players’Ranking Shift (2024 vs 2025) (Based on Revenue)
 Table 12. Global Companies by Tier (Tier 1, Tier 2, and Tier 3), based on AI Imaging & Diagnostics Revenue, 2025
 Table 13. Global AI Imaging & Diagnostics Average Gross Margin (%) by Player (2021 vs 2025)
 Table 14. Global AI Imaging & Diagnostics Companies Headquarters
 Table 15. Global AI Imaging & Diagnostics Market Concentration Ratio (CR5)
 Table 16. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
 Table 17. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 18. Global AI Imaging & Diagnostics Revenue by Type (US$ Million), 2021-2026
 Table 19. Global AI Imaging & Diagnostics Revenue by Type (US$ Million), 2027-2032
 Table 20. Global AI Imaging & Diagnostics Revenue by Diagnostic Data Type (US$ Million), 2021-2026
 Table 21. Global AI Imaging & Diagnostics Revenue by Diagnostic Data Type (US$ Million), 2027-2032
 Table 22. Global AI Imaging & Diagnostics Revenue by Deployment & Delivery (US$ Million), 2021-2026
 Table 23. Global AI Imaging & Diagnostics Revenue by Deployment & Delivery (US$ Million), 2027-2032
 Table 24. Key Product Attributes and Differentiation
 Table 25. Global AI Imaging & Diagnostics Revenue by Application (US$ Million), 2021-2026
 Table 26. Global AI Imaging & Diagnostics Revenue by Application (US$ Million), 2027-2032
 Table 27. AI Imaging & Diagnostics High-Growth Sectors Demand CAGR (2026-2032)
 Table 28. Top Customers by Region
 Table 29. Top Customers by Application
 Table 30. North America AI Imaging & Diagnostics Growth Accelerators and Market Barriers
 Table 31. North America AI Imaging & Diagnostics Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
 Table 32. Europe AI Imaging & Diagnostics Growth Accelerators and Market Barriers
 Table 33. Europe AI Imaging & Diagnostics Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 34. Asia-Pacific AI Imaging & Diagnostics Growth Accelerators and Market Barriers
 Table 35. Asia-Pacific AI Imaging & Diagnostics Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Central and South America AI Imaging & Diagnostics Investment Opportunities and Key Challenges
 Table 37. Central and South America AI Imaging & Diagnostics Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
 Table 38. Middle East and Africa AI Imaging & Diagnostics Investment Opportunities and Key Challenges
 Table 39. Middle East and Africa AI Imaging & Diagnostics Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
 Table 40. Butterfly Network Corporation Information
 Table 41. Butterfly Network Description and Major Businesses
 Table 42. Butterfly Network Product Features and Attributes
 Table 43. Butterfly Network Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 44. Butterfly Network Revenue Proportion by Product in 2025
 Table 45. Butterfly Network Revenue Proportion by Application in 2025
 Table 46. Butterfly Network Revenue Proportion by Geographic Area in 2025
 Table 47. Butterfly Network AI Imaging & Diagnostics SWOT Analysis
 Table 48. Butterfly Network Recent Developments
 Table 49. Merative Corporation Information
 Table 50. Merative Description and Major Businesses
 Table 51. Merative Product Features and Attributes
 Table 52. Merative Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 53. Merative Revenue Proportion by Product in 2025
 Table 54. Merative Revenue Proportion by Application in 2025
 Table 55. Merative Revenue Proportion by Geographic Area in 2025
 Table 56. Merative AI Imaging & Diagnostics SWOT Analysis
 Table 57. Merative Recent Developments
 Table 58. Tempus Corporation Information
 Table 59. Tempus Description and Major Businesses
 Table 60. Tempus Product Features and Attributes
 Table 61. Tempus Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 62. Tempus Revenue Proportion by Product in 2025
 Table 63. Tempus Revenue Proportion by Application in 2025
 Table 64. Tempus Revenue Proportion by Geographic Area in 2025
 Table 65. Tempus AI Imaging & Diagnostics SWOT Analysis
 Table 66. Tempus Recent Developments
 Table 67. RetinAi Corporation Information
 Table 68. RetinAi Description and Major Businesses
 Table 69. RetinAi Product Features and Attributes
 Table 70. RetinAi Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 71. RetinAi Revenue Proportion by Product in 2025
 Table 72. RetinAi Revenue Proportion by Application in 2025
 Table 73. RetinAi Revenue Proportion by Geographic Area in 2025
 Table 74. RetinAi AI Imaging & Diagnostics SWOT Analysis
 Table 75. RetinAi Recent Developments
 Table 76. Nanox Corporation Information
 Table 77. Nanox Description and Major Businesses
 Table 78. Nanox Product Features and Attributes
 Table 79. Nanox Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 80. Nanox Revenue Proportion by Product in 2025
 Table 81. Nanox Revenue Proportion by Application in 2025
 Table 82. Nanox Revenue Proportion by Geographic Area in 2025
 Table 83. Nanox AI Imaging & Diagnostics SWOT Analysis
 Table 84. Nanox Recent Developments
 Table 85. Lunit Corporation Information
 Table 86. Lunit Description and Major Businesses
 Table 87. Lunit Product Features and Attributes
 Table 88. Lunit Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 89. Lunit Recent Developments
 Table 90. DiA Imaging Corporation Information
 Table 91. DiA Imaging Description and Major Businesses
 Table 92. DiA Imaging Product Features and Attributes
 Table 93. DiA Imaging Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 94. DiA Imaging Recent Developments
 Table 95. Subtle Medical Corporation Information
 Table 96. Subtle Medical Description and Major Businesses
 Table 97. Subtle Medical Product Features and Attributes
 Table 98. Subtle Medical Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 99. Subtle Medical Recent Developments
 Table 100. BrainMiner Corporation Information
 Table 101. BrainMiner Description and Major Businesses
 Table 102. BrainMiner Product Features and Attributes
 Table 103. BrainMiner Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 104. BrainMiner Recent Developments
 Table 105. GE Corporation Information
 Table 106. GE Description and Major Businesses
 Table 107. GE Product Features and Attributes
 Table 108. GE Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 109. GE Recent Developments
 Table 110. Siemens Corporation Information
 Table 111. Siemens Description and Major Businesses
 Table 112. Siemens Product Features and Attributes
 Table 113. Siemens Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 114. Siemens Recent Developments
 Table 115. Aidoc Corporation Information
 Table 116. Aidoc Description and Major Businesses
 Table 117. Aidoc Product Features and Attributes
 Table 118. Aidoc Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 119. Aidoc Recent Developments
 Table 120. Imagen Technologies, Inc. Corporation Information
 Table 121. Imagen Technologies, Inc. Description and Major Businesses
 Table 122. Imagen Technologies, Inc. Product Features and Attributes
 Table 123. Imagen Technologies, Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 124. Imagen Technologies, Inc. Recent Developments
 Table 125. VUNO, Inc. Corporation Information
 Table 126. VUNO, Inc. Description and Major Businesses
 Table 127. VUNO, Inc. Product Features and Attributes
 Table 128. VUNO, Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 129. VUNO, Inc. Recent Developments
 Table 130. Digital Diagnostics Corporation Information
 Table 131. Digital Diagnostics Description and Major Businesses
 Table 132. Digital Diagnostics Product Features and Attributes
 Table 133. Digital Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 134. Digital Diagnostics Recent Developments
 Table 135. NeuraSignal Corporation Information
 Table 136. NeuraSignal Description and Major Businesses
 Table 137. NeuraSignal Product Features and Attributes
 Table 138. NeuraSignal Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 139. NeuraSignal Recent Developments
 Table 140. Riverain Technologies, LLC Corporation Information
 Table 141. Riverain Technologies, LLC Description and Major Businesses
 Table 142. Riverain Technologies, LLC Product Features and Attributes
 Table 143. Riverain Technologies, LLC Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 144. Riverain Technologies, LLC Recent Developments
 Table 145. Philips Corporation Information
 Table 146. Philips Description and Major Businesses
 Table 147. Philips Product Features and Attributes
 Table 148. Philips Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 149. Philips Recent Developments
 Table 150. Microsoft Corporation Information
 Table 151. Microsoft Description and Major Businesses
 Table 152. Microsoft Product Features and Attributes
 Table 153. Microsoft Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 154. Microsoft Recent Developments
 Table 155. Viz.ai Corporation Information
 Table 156. Viz.ai Description and Major Businesses
 Table 157. Viz.ai Product Features and Attributes
 Table 158. Viz.ai Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 159. Viz.ai Recent Developments
 Table 160. RapidAI Corporation Information
 Table 161. RapidAI Description and Major Businesses
 Table 162. RapidAI Product Features and Attributes
 Table 163. RapidAI Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 164. RapidAI Recent Developments
 Table 165. Canon Medical Corporation Information
 Table 166. Canon Medical Description and Major Businesses
 Table 167. Canon Medical Product Features and Attributes
 Table 168. Canon Medical Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 169. Canon Medical Recent Developments
 Table 170. Enlitic Corporation Information
 Table 171. Enlitic Description and Major Businesses
 Table 172. Enlitic Product Features and Attributes
 Table 173. Enlitic Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 174. Enlitic Recent Developments
 Table 175. BioMind Corporation Information
 Table 176. BioMind Description and Major Businesses
 Table 177. BioMind Product Features and Attributes
 Table 178. BioMind Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 179. BioMind Recent Developments
 Table 180. ANNALISE-AI PTY LTD Corporation Information
 Table 181. ANNALISE-AI PTY LTD Description and Major Businesses
 Table 182. ANNALISE-AI PTY LTD Product Features and Attributes
 Table 183. ANNALISE-AI PTY LTD Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 184. ANNALISE-AI PTY LTD Recent Developments
 Table 185. icometrix Corporation Information
 Table 186. icometrix Description and Major Businesses
 Table 187. icometrix Product Features and Attributes
 Table 188. icometrix Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 189. icometrix Recent Developments
 Table 190. KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO） Corporation Information
 Table 191. KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO） Description and Major Businesses
 Table 192. KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO） Product Features and Attributes
 Table 193. KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO） Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 194. KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO） Recent Developments
 Table 195. Technologies, Platforms and Infrastructure
 Table 196. Distributors List
 Table 197. Market Trends and Market Evolution
 Table 198. Market Drivers and Opportunities
 Table 199. Market Challenges, Risks, and Restraints
 Table 200. Research Programs/Design for This Report
 Table 201. Key Data Information from Secondary Sources
 Table 202. Key Data Information from Primary Sources


List of Figures
 Figure 1. Global AI Imaging & Diagnostics Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
 Figure 2. X-ray / CXR Product Picture
 Figure 3. CT Product Picture
 Figure 4. MRI Product Picture
 Figure 5. Ultrasound Product Picture
 Figure 6. Mammography / DBT Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global AI Imaging & Diagnostics Market Size Growth Rate by Diagnostic Data Type, 2021 vs 2025 vs 2032 (US$ Million)
 Figure 9. Medical Imaging–based Product Picture
 Figure 10. Physiological Signals–based Product Picture
 Figure 11. Ophthalmic Imaging–based Product Picture
 Figure 12. Others Product Picture
 Figure 13. Global AI Imaging & Diagnostics Market Size Growth Rate by Deployment & Delivery, 2021 vs 2025 vs 2032 (US$ Million)
 Figure 14. On-prem Product Picture
 Figure 15. Cloud SaaS Product Picture
 Figure 16. Edge / Embedded Product Picture
 Figure 17. Hybrid Product Picture
 Figure 18. Others Product Picture
 Figure 19. Global AI Imaging & Diagnostics Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
 Figure 20. Radiology & Imaging
 Figure 21. Cardiology
 Figure 22. Neurology
 Figure 23. Ophthalmology
 Figure 24. Oncology
 Figure 25. Primary Care
 Figure 26. Others
 Figure 27. AI Imaging & Diagnostics Report Years Considered
 Figure 28. Global AI Imaging & Diagnostics Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 29. Global AI Imaging & Diagnostics Revenue (US$ Million), 2021-2032
 Figure 30. Global AI Imaging & Diagnostics Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Figure 31. Global AI Imaging & Diagnostics Revenue-Based Market Share by Region (2021-2032)
 Figure 32. Global AI Imaging & Diagnostics Revenue-Based Market Share Ranking (2025)
 Figure 33. Tier Distribution by Revenue Contribution (2021 vs 2025)
 Figure 34. X-ray / CXR Revenue-Based Market Share by Player in 2025
 Figure 35. CT Revenue-Based Market Share by Player in 2025
 Figure 36. MRI Revenue-Based Market Share by Player in 2025
 Figure 37. Ultrasound Revenue-Based Market Share by Player in 2025
 Figure 38. Mammography / DBT Revenue-Based Market Share by Player in 2025
 Figure 39. Others Revenue-Based Market Share by Player in 2025
 Figure 40. Global AI Imaging & Diagnostics Revenue-Based Market Share by Type (2021-2032)
 Figure 41. Global AI Imaging & Diagnostics Revenue-Based Market Share by Diagnostic Data Type (2021-2032)
 Figure 42. Global AI Imaging & Diagnostics Revenue-Based Market Share by Deployment & Delivery (2021-2032)
 Figure 43. Global AI Imaging & Diagnostics Revenue-Based Market Share by Application (2021-2032)
 Figure 44. North America AI Imaging & Diagnostics Revenue YoY (US$ Million), 2021-2032
 Figure 45. North America Top 5 Players AI Imaging & Diagnostics Revenue (US$ Million) in 2025
 Figure 46. North America AI Imaging & Diagnostics Revenue (US$ Million) by Application (2021-2032)
 Figure 47. US AI Imaging & Diagnostics Revenue (US$ Million), 2021-2032
 Figure 48. Canada AI Imaging & Diagnostics Revenue (US$ Million), 2021-2032
 Figure 49. Mexico AI Imaging & Diagnostics Revenue (US$ Million), 2021-2032
 Figure 50. Europe AI Imaging & Diagnostics Revenue YoY (US$ Million), 2021-2032
 Figure 51. Europe Top 5 Players AI Imaging & Diagnostics Revenue (US$ Million) in 2025
 Figure 52. Europe AI Imaging & Diagnostics Revenue (US$ Million) by Application (2021-2032)
 Figure 53. Germany AI Imaging & Diagnostics Revenue (US$ Million), 2021-2032
 Figure 54. France AI Imaging & Diagnostics Revenue (US$ Million), 2021-2032
 Figure 55. U.K. AI Imaging & Diagnostics Revenue (US$ Million), 2021-2032
 Figure 56. Italy AI Imaging & Diagnostics Revenue (US$ Million), 2021-2032
 Figure 57. Russia AI Imaging & Diagnostics Revenue (US$ Million), 2021-2032
 Figure 58. Asia-Pacific AI Imaging & Diagnostics Revenue YoY (US$ Million), 2021-2032
 Figure 59. Asia-Pacific Top 8 Players AI Imaging & Diagnostics Revenue (US$ Million) in 2025
 Figure 60. Asia-Pacific AI Imaging & Diagnostics Revenue (US$ Million) by Application (2021-2032)
 Figure 61. Indonesia AI Imaging & Diagnostics Revenue (US$ Million), 2021-2032
 Figure 62. Japan AI Imaging & Diagnostics Revenue (US$ Million), 2021-2032
 Figure 63. South Korea AI Imaging & Diagnostics Revenue (US$ Million), 2021-2032
 Figure 64. Australia AI Imaging & Diagnostics Revenue (US$ Million), 2021-2032
 Figure 65. India AI Imaging & Diagnostics Revenue (US$ Million), 2021-2032
 Figure 66. Indonesia AI Imaging & Diagnostics Revenue (US$ Million), 2021-2032
 Figure 67. Vietnam AI Imaging & Diagnostics Revenue (US$ Million), 2021-2032
 Figure 68. Malaysia AI Imaging & Diagnostics Revenue (US$ Million), 2021-2032
 Figure 69. Philippines AI Imaging & Diagnostics Revenue (US$ Million), 2021-2032
 Figure 70. Singapore AI Imaging & Diagnostics Revenue (US$ Million), 2021-2032
 Figure 71. Central and South America AI Imaging & Diagnostics Revenue YoY (US$ Million), 2021-2032
 Figure 72. Central and South America Top 5 Players AI Imaging & Diagnostics Revenue (US$ Million) in 2025
 Figure 73. Central and South America AI Imaging & Diagnostics Revenue (US$ Million) by Application (2021-2032)
 Figure 74. Brazil AI Imaging & Diagnostics Revenue (US$ Million), 2021-2032
 Figure 75. Argentina AI Imaging & Diagnostics Revenue (US$ Million), 2021-2032
 Figure 76. Middle East and Africa AI Imaging & Diagnostics Revenue YoY (US$ Million), 2021-2032
 Figure 77. Middle East and Africa Top 5 Players AI Imaging & Diagnostics Revenue (US$ Million) in 2025
 Figure 78. Middle East and Africa AI Imaging & Diagnostics Revenue (US$ Million) by Application (2021-2032)
 Figure 79. GCC Countries AI Imaging & Diagnostics Revenue (US$ Million), 2021-2032
 Figure 80. Israel AI Imaging & Diagnostics Revenue (US$ Million), 2021-2032
 Figure 81. Egypt AI Imaging & Diagnostics Revenue (US$ Million), 2021-2032
 Figure 82. South Africa AI Imaging & Diagnostics Revenue (US$ Million), 2021-2032
 Figure 83. AI Imaging & Diagnostics Value Chain Mapping
 Figure 84. Channels of Distribution (Direct Vs Distribution)
 Figure 85. Bottom-up and Top-down Approaches for This Report
 Figure 86. Data Triangulation
 Figure 87. Key Executives Interviewed

Description

The global AI Imaging & Diagnostics market is projected to grow from US$ 7259 million in 2025 to US$ 27453 million by 2032, at a CAGR of 20.9% (2026-2032), driven by critical product segments and diverse end‑use applications.

AI Imaging & Diagnostics refers to the integrated market of artificial intelligence technologies applied to medical imaging analysis and broader clinical diagnostic decision-making. It includes AI systems that analyze imaging data such as X-ray, CT, MRI, ultrasound, mammography, and digital pathology, as well as solutions that combine imaging with non-imaging clinical inputs (e.g., physiological signals, structured EHR data) to support diagnosis. These products are typically commercialized as regulated Software as a Medical Device (SaMD) or embedded into imaging equipment and clinical IT systems such as PACS, RIS, and EHRs. AI Imaging & Diagnostics enhances diagnostic accuracy, standardization, and efficiency while keeping physicians in the loop, addressing rising imaging volumes, workforce shortages, and the need for earlier and more consistent disease detection.

A concise Industry‑chain overview maps upstream, middle stream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Chapter Outline
Chapter 1: Defines the AI Imaging & Diagnostics study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape: ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down market size by Application and country, profiles key players and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional market by Application and players, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies market size by Application, and region/country, profiles top players, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures market size by Application, and country, profiles top players, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates market size by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth: details product specs, revenue, margins; top-tier players 2025 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments
Chapter 12: Value chain and ecosystem: analyses upstream, midstream, plus downstream channels
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

Related Reports

AI Imaging & Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI Imaging & Diagnostics was estimated to be worth US$ 7259 million in 2025 and is projected to reach US$ 27453 million, growing at a CAGR of 20.9% from 2026 to 2032.
Published: 2026-03-10
Pages: 178
USD 3950.00
(Single User License)
Global AI Imaging & Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global AI Imaging & Diagnostics market size was US$ 7259 million in 2025 and is forecast to reach a readjusted size of US$ 27453 million by 2032 with a CAGR of 20.9% during the forecast period 2026-2032.
Published: 2026-03-10
Pages: 126
USD 4250.00
(Single User License)
Global AI Imaging & Diagnostics Market Research Report 2026
The global AI Imaging & Diagnostics market was valued at US$ 7259 million in 2025 and is anticipated to reach US$ 27453 million by 2032, at a CAGR of 20.9% from 2026 to 2032.
Published: 2026-03-10
Pages: 166
USD 2900.00
(Single User License)

AI Imaging & Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI Imaging & Diagnostics was estimated to be worth US$ 7259 million in 2025 and is projected to reach US$ 27453 million, growing at a CAGR of 20.9% from 2026 to 2032.
Published: 2026-03-10
Pages: 178
USD 3950.00 (Single User License)
Global AI Imaging & Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global AI Imaging & Diagnostics market size was US$ 7259 million in 2025 and is forecast to reach a readjusted size of US$ 27453 million by 2032 with a CAGR of 20.9% during the forecast period 2026-2032.
Published: 2026-03-10
Pages: 126
USD 4250.00 (Single User License)
Global AI Imaging & Diagnostics Market Research Report 2026
The global AI Imaging & Diagnostics market was valued at US$ 7259 million in 2025 and is anticipated to reach US$ 27453 million by 2032, at a CAGR of 20.9% from 2026 to 2032.
Published: 2026-03-10
Pages: 166
USD 2900.00 (Single User License)